19. 05. 2025

CTP 為肖特製藥公司在塞爾維亞建造 18,000 平方米的工廠，擴大其全球製造網絡

#C 公司 #CTParks #Press Releases 1TP5投资者关系

Amsterdam, 19 May 2025 – CTP, Europe’s largest listed developer, owner, and manager of industrial and logistics properties by gross lettable area (GLA), has developed a new 18,000 sqm build-to-suit production facility for SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, at CTPark Jagodina in Serbia.

SCHOTT Pharma will produce high-quality glass ampoules for vaccines and other medications from the industrial property, which marks an expansion of the company’s global manufacturing network that now spans 15 countries.

180 people will be employed at the facility, which complements SCHOTT Pharma’s 10 existing ampoule manufacturing sites across the globe, helping to safely deliver billions of injections every year. The property also benefits from CTP’s high-quality modern building standards and sustainability-focused design.

CTPark Jagodina offers outstanding regional connectivity, located just off Serbia’s A1 highway and within reach of major cities including Belgrade (135 km), Niš (100 km), and multiple EU markets via direct road links. With a population of 400,000 within a 50 km radius and proximity to 20,000 students in nearby Kragujevac, the Park also provides access to skilled labour.

CTPark Jagodina features energy-efficient buildings with BREEAM Very Good certifications, rooftop solar technology, water reuse systems, and modern amenities designed to support biodiversity and employee wellbeing. The park spans 22.9 hectares with 33,000 sqm of space already built, with 88,000 sqm planned for new development.

Petar Kolognat, Business Development Director for CTP Serbia, commented:

“This partnership with SCHOTT Pharma is another shining example of how we support leading businesses in high-tech sectors by providing them with the strategic locations and scalable facilities they need. We are with our clients at every stage of their logistics property journeys, from site selection to construction, to the day-to-day management of their facilities. This ensures we understand our clients’ individual needs and can deliver the real estate solutions that enable their businesses and people to thrive. SCHOTT Pharma’s presence at CTPark Jagodina strengthens not only the park but the region’s wider industrial ecosystem. The Park also provides SCHOTT Pharma with the flexibility to grow into more space with ample land available for new development.”

Denis Nikitin, Plant Manager at SCHOTT Pharma, said:

“We are very pleased with the support given by CTP from the start of the analysis and location search for our new plant all the way to the handover of the building. CTP offered and secured the most suitable location, surrounded by skilled workers in one of the most important industrial regions in Serbia. Through a close exchange of expertise with our teams across Europe and improved equipment, we look forward to reliably supplying our customers with the highest quality products from this location.”

CTP is the leading developer of industrial and logistics properties in Serbia, managing a total gross leasable area (GLA) of 600,000 sqm with an additional 200,000 sqm to be delivered in 2025. Serbia has become an attractive manufacturing destination for multinationals nearshoring their production to Europe to be closer to where their customers are located as they look to derisk supply chains and meet new EU regulations encouraging more production on the continent.

CTP’s parks are strategically located in Serbia’s largest cities, including Belgrade, Novi Sad, Kragujevac, Jagodina, and Niš. Examples include CTPark Belgrade North and CTPark Belgrade West that offer Grade A logistics facilities with excellent transportation links to major European cities. They are also conveniently located near Nikola Tesla International Airport providing easy access to Europe’s markets.

关于 CTP
CTP 是歐洲以可出租總面積計算最大的上市物流和工業房地產所有者、開發商和管理者，截至 2025 年 3 月 31 日，其在 10 個國家/地區擁有 1340 萬平方米的可出租總面積。 CTP 對所有新建築均按照 BREEAM 進行非常好或更好的認證，並獲得 Sustainalytics 頒發的可忽略不計風險 ESG 評級，彰顯了其致力於成為可持續發展企業的承諾。欲了解更多信息，請訪問 CTP 的公司網站： www.ctp.eu.

联系方式
媒体垂询联系方式：
Patryk Statkiewicz，集团营销与公关负责人
手机： +31 (0) 629 596 119+31 (0) 629 596 119
电子邮件： patryk.statkiewicz@ctp.eu

SEC 新门
詹姆斯-卡内基
手机： +44 (0)7827 486 224+44 (0)7827 486 224
电子邮件CTP@SECNewgate.co.uk

分析师和投资者咨询的详细联系方式：
投资者关系主管 Maarten Otte
手机： +420 730 197 500+420 730 197 500
电子邮件： maarten.otte@ctp.eu

英文版

CTP 為肖特製藥公司在塞爾維亞建造 18,000 平方米的工廠，擴大其全球製造網絡

商業聯絡

園區地址

CTP 為肖特製藥公司在塞爾維亞建造 18,000 平方米的工廠，擴大其全球製造網絡

訂閱電子報

商業聯絡

園區地址